METHYLPHENIDATE
Clinical Indication
Excessive sleepiness caused by narcolepsy
Comments
Date of classification
March 2022
Orange
Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.